Accreditation & Objectives

Target Audience

This program is intended for cardiologists, endocrinologists, internists and primary care physicians and other healthcare professionals who wish to specialize and become certified by the American Board of Clinical Lipidology (ABCL), the Accreditation Council for Clinical Lipidology (ACCL), or who desire advanced training in the management of dyslipidemias and the metabolic syndrome.

Learning Objectives

Upon completion of this course, you will be better able to:

• Discuss lipoprotein metabolism and the role of the vascular system in the pathogenesis of atherosclerosis
• Manage dyslipidemias according to patient profiles
• Assess traditional and emerging markers for atherosclerotic cardiovascular disease
• Recognize the role of drug therapies, nutrition, and therapeutic life style changes in the management of dyslipidemias
• Manage cardiometabolic risk factors of the metabolic syndrome
• Explain the role genetic disorders play in lipoprotein metabolism

Accrreditation Statement

The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Lipid Association designates this educational activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Commercial Support

This activity is supported in part through an educational grant from AstraZeneca. It is the policy of the National Lipid Association to adhere to ACCME Essential Areas, Policies, and Standards for Commercial Support in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs.